Skip to main content

Trust & Security Centre

How Lazomis QI protects your information

Lazomis QI is designed for non-identifiable clinical audit and quality-improvement information. It must not be used to store patient-identifiable information.

Organisational requirements vary. Healthcare professionals should follow their employer’s procedures for registering audits, approving quality-improvement work and using external digital platforms.

Lazomis QI is operated by Flux Medical Limited, which is registered with the Information Commissioner’s Office. Lazomis QI does not sell users’ clinical audit information.

Non-identifiable by design

No patient names, NHS numbers or hospital numbers are needed to run a project.

Controlled access

Encrypted connections, authenticated accounts and role-based project access.

Your policies still apply

Local audit registration and information-governance requirements remain with you.

At a glance

  • Lazomis QI is designed for anonymised clinical audit and quality-improvement data.
  • Patient-identifiable information must not be entered. Local approval does not override this.
  • Local audit registration and your organisation’s requirements still apply.
  • Hosted on secure cloud infrastructure in the UK and EU; encrypted connections, authenticated accounts and server-enforced, role-based project access.
  • AI features assist with drafting and summarising, and every output is reviewed by the user. Provider arrangements are available through direct discussion.
  • Flux Medical Limited is registered with the ICO and has completed and published a Data Security and Protection Toolkit submission.
  • Organisations can discuss governance and security directly with Lazomis using the contact route on this page.

Using the platform safely

What information can be entered into Lazomis QI?

Non-identifiable clinical audit and quality-improvement information: whether a standard was met, structured audit criteria, dates of activity at the level your project needs, care setting, specialty, and locally generated audit references that do not identify a patient.

What information must never be entered?

Patient names, NHS numbers, hospital or medical-record numbers, full dates of birth, addresses, contact details, identifiable free text, or any other information that could identify an individual patient.

Does Lazomis QI require patient-identifiable information?

No. Lazomis QI does not require patient names, NHS numbers or hospital numbers. Where a case reference is needed, use a locally generated reference that does not identify the patient.

Is pseudonymised information the same as anonymous information?

No. Information may remain personal data if an individual could be identified using other information, and a patient code alone does not make a dataset anonymous. Do not enter reversible patient codes or identifiers; local organisational approval does not override this restriction.

Can I use Lazomis QI without organisational approval?

Requirements vary between organisations and projects. You must follow your organisation’s procedures for registering clinical audits, approving quality-improvement work and using external digital platforms. If you are uncertain, contact your clinical audit, quality-improvement or information-governance team.

Who is responsible for registering or approving an audit locally?

Local registration and approval remain the responsibility of the user and their organisation. Lazomis QI supports the structure, data collection, analysis and reporting of a project; it does not register or approve projects on an organisation’s behalf.

How information is handled

Where is information hosted?

Information is hosted on secure cloud infrastructure within the UK and the EU.

How is information protected?

Connections to the platform are encrypted in transit, access requires an authenticated account, and project information is separated by organisation and project with role-based permissions enforced on the server. Activity on projects, submissions and outputs is recorded for accountability. Further technical detail is available through direct discussion. See also our Governance & Security page.

Who can access project information?

Only the people given access to that project: the project owner, invited team members and, within an organisation workspace, the administrators of that organisation. A small number of Lazomis administrators can access systems for support, security and maintenance purposes.

Does Lazomis sell clinical audit information?

No. Lazomis QI does not sell users’ clinical audit information.

Is information used to train public AI models?

Available through direct discussion. AI features assist with drafting and summarising and are always reviewed by the user; details of the provider arrangements that apply can be discussed with your information-governance team. See our AI Policy.

How long is information retained?

Project information is retained while your account and project remain active, so that you can continue, re-audit and evidence your work. Retention detail for a specific organisational arrangement is available through direct discussion. See the Privacy Policy and Data Protection pages.

Can a user delete a project or account?

Yes. Projects can be deleted from your workspace, and you can ask us to close your account and remove your personal information. Requests can be made through our privacy enquiry route.

What happens if an account or security incident is suspected?

Contact us immediately through the contact page or a privacy enquiry. We investigate suspected account compromise and security incidents, take action to protect accounts and data, and notify affected users and, where applicable, the Information Commissioner’s Office in line with our obligations.

Registration, assurance and contact

Is Flux Medical Limited registered with the ICO?

Completed. Lazomis QI is operated by Flux Medical Limited, which is registered with the Information Commissioner’s Office.

What is the status of the Data Security and Protection Toolkit?

Completed. Flux Medical Limited has completed and published a Data Security and Protection Toolkit submission. The published record can be confirmed with us on request.

What is the status of DTAC assessment?

In progress. A Digital Technology Assessment Criteria response is being prepared. Organisation-specific assessment is normally required, and we can discuss the information you need for your own review.

What information can be discussed with organisations considering the platform?

Available through direct discussion. We can discuss the platform, its intended data boundary, access controls, hosting arrangements and the information required to support local data-protection, information-governance, clinical-safety and digital-technology assessments.

How can an audit, governance, data-protection or information-governance team contact Lazomis?

Use the “Discuss governance and security” button on this page, or the contact page. Data-protection questions can also be sent through our privacy enquiry route.

Where can users find the Privacy Policy and other existing governance or security information?

Our detailed policies remain available in full: Privacy Policy, Terms of Use, Data Protection, Governance & Security, Cookie Policy and the AI Policy. This Trust & Security Centre summarises them in plain English; it does not replace them.

Information for organisations

Healthcare organisations may need to review Lazomis QI before approving organisation-wide use. Supporting information about the platform, its intended data boundary and relevant safeguards is available through direct discussion with Lazomis.

We can discuss the information required to support local data-protection, information-governance, clinical-safety and digital-technology assessments.

This page complements, and does not replace, our Privacy Policy, Terms of Use and Governance & Security information.